Clinical trials
Completed Precursor Cell Lymphoblastic Leukemia-Lymphoma trials in Austria
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2003 | 1 |
| 2005 | 3 |
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 3 |
| 2017 | 1 |
| 2020 | 1 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 6 |
| Amgen | 3 |
| Amgen Research (Munich) GmbH | 2 |
| Bristol-Myers Squibb | 2 |
| Charite University, Berlin, Germany | 1 |
| Genzyme, a Sanofi Company | 1 |
| International BFM Study Group | 1 |
| Medical University of Vienna | 1 |
| University Hospital Schleswig-Holstein | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 18 |
| Leukemia | 5 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 4 |
| Burkitt Lymphoma | 3 |
| Lymphoproliferative Disorders | 3 |
| Recurrence | 3 |
| Immunoproliferative Disorders | 2 |
| Lymphatic Diseases | 2 |
| Neoplasms | 2 |
| Death | 1 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.